Published in J Opioid Manag on October 25, 2007
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry (2008) 1.40
Prescription opioid misuse and mental health among young injection drug users. Am J Drug Alcohol Abuse (2014) 0.79
The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry (2009) 4.10
The genetic determinants of smoking. Chest (2003) 2.88
Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend (2007) 2.11
Psychiatric symptoms and substance use disorders in a nationally representative sample of American adolescents involved with foster care. J Adolesc Health (2006) 1.91
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol (2006) 1.57
Buprenorphine treatment: factors and first-hand experiences for providers to consider. J Addict Dis (2007) 1.46
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry (2011) 1.45
The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Subst Abuse Rehabil (2012) 1.44
Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. J Addict Dis (2004) 1.43
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry (2008) 1.40
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study. Am J Addict (2007) 1.37
The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. Am J Geriatr Psychiatry (2009) 1.31
Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use. Drug Alcohol Depend (2007) 1.27
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
Screening for alcohol and drug use disorders among adults in primary care: a review. Subst Abuse Rehabil (2012) 1.26
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav (2013) 1.14
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials (2008) 1.14
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
Alcohol and drug use disorders among adults in emergency department settings in the United States. Ann Emerg Med (2012) 1.11
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics (2009) 1.10
Nonprescription use of pain relievers by middle-aged and elderly community-living adults: National Survey on Drug Use and Health. J Am Geriatr Soc (2009) 1.09
Substance abuse, treatment needs and access among female sex workers and non-sex workers in Pretoria, South Africa. Subst Abuse Treat Prev Policy (2009) 1.07
The epidemiology of alcohol use disorders and subthreshold dependence in a middle-aged and elderly community sample. Am J Geriatr Psychiatry (2011) 1.06
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl) (2009) 1.05
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs (2011) 1.05
Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Subst Abuse Rehabil (2013) 1.04
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03
Alcohol limits in older people. Addiction (2012) 1.02
Paroxetine mesylate: comparable to paroxetine hydrochloride? Expert Opin Pharmacother (2010) 1.02
Substance abuse among individuals with intellectual disabilities. Res Dev Disabil (2012) 0.99
Changes in tobacco smoking following treatment for cocaine dependence. Am J Drug Alcohol Abuse (2006) 0.99
Patterns of tobacco use and tobacco-related psychiatric morbidity and substance use among middle-aged and older adults in the United States. Aging Ment Health (2012) 0.99
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol (2009) 0.98
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. J Clin Psychiatry (2012) 0.98
Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil (2011) 0.98
Does minocycline have antidepressant effect? Biomed Pharmacother (2008) 0.97
Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network. Am J Drug Alcohol Abuse (2011) 0.97
Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications. Clin Neuropharmacol (2011) 0.97
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict Biol (2008) 0.96
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95
Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse (2011) 0.95
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr (2010) 0.95
Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. Depress Anxiety (2007) 0.95
Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. Prim Care Companion J Clin Psychiatry (2006) 0.93
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology (2011) 0.93
A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics (2009) 0.93
A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med (2007) 0.91
Postpartum substance use and depressive symptoms: a review. Women Health (2013) 0.91
Hallucinogen use disorders among adult users of MDMA and other hallucinogens. Am J Addict (2008) 0.91
Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse (2005) 0.91
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network. Subst Abuse Rehabil (2011) 0.90
Triple reuptake inhibitors: the next generation of antidepressants. Curr Neuropharmacol (2008) 0.90
Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults. Gen Hosp Psychiatry (2012) 0.90
Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Rev Neurother (2007) 0.90
The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin (2008) 0.90
Paroxetine: current status in psychiatry. Expert Rev Neurother (2007) 0.90
A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatr Genet (2005) 0.90
The distribution of cocaine in mice differs by age and strain. Neurotoxicol Teratol (2004) 0.89
Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study. Am J Addict (2008) 0.89
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS Drugs (2008) 0.89
Short-, intermediate-, and long-term outcomes of Pennsylvania's continuum of tobacco education pilot project. Nicotine Tob Res (2009) 0.89
Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependent patients. Am J Addict (2005) 0.88
An integrated alcohol abuse and medical treatment model for patients with hepatitis C. Dig Dis Sci (2011) 0.88
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. J Clin Psychiatry (2010) 0.87
Quetiapine XR: current status for the treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.87
Substance Use among Adolescent Mothers: A Review. Child Youth Serv Rev (2013) 0.87
Recent advances in poststroke depression. Curr Psychiatry Rep (2007) 0.87
Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res (2006) 0.87
Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics. Eur Arch Psychiatry Clin Neurosci (2011) 0.87
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother (2008) 0.86
Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine-, and multisubstance-dependent patients. J Addict Dis (2004) 0.86
Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. J Psychiatr Res (2013) 0.86
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Rev Neurother (2013) 0.85
Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. Am J Med Genet B Neuropsychiatr Genet (2005) 0.85
Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals. Addict Biol (2005) 0.85
A review of current evidence for vilazodone in major depressive disorder. Int J Psychiatry Clin Pract (2013) 0.85
Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.85
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur J Pharmacol (2007) 0.84
Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients. Psychopharmacology (Berl) (2006) 0.83
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram. J Clin Psychiatry (2013) 0.83
Long-acting injectable naltrexone for the treatment of alcohol dependence. Expert Rev Neurother (2007) 0.83
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Subst Abuse Rehabil (2011) 0.83
Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. Psychiatry Res (2006) 0.83
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother (2009) 0.83
Atypical depression: a comprehensive review. CNS Drugs (2009) 0.83
Association Between Substance Use and Gun-Related Behaviors. Epidemiol Rev (2016) 0.82
Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse (2011) 0.82
Polypharmacy in pregnant women with major psychiatric illness: a pilot study. J Psychiatr Pract (2007) 0.82